Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (868)	2/19/1999 1:00:00 AM
From: Beltropolis Boy	Read Replies (2) \| Respond to of 1686

>Speaking of potential new upgrades, how about one from JPM ... Now what's missing from this picture? Oh yeah, a stock split. no shit -- i don't know what peter piper's got packed in his pipe either, but i'm guessing his "target price" must be post-split too. <vbg> didn't we close at $91 and (lots of) change? ----- Biogen Inc. Reiterated 'Buy' at Piper Jaffray Princeton, New Jersey, Feb. 18 (Bloomberg Data) -- Biogen Inc. (BGEN US) was reiterated ''buy'' by analyst Peter L. Ginsberg at Piper Jaffray Inc. The 12-month target price is $90.00 per share.